Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine
- 25 October 2021
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (2) , 304-307
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 2020
- Severe acute anemia attributable to concomitant occurrence of AIHA with PRCA induced by parvovirus B19 infectionBlood, 2018
- Pure red-cell aplasia and autoimmune hemolytic anemia in a patient with acute hepatitis AClinical and Molecular Hepatology, 2014
- Pure red cell aplasia following autoimmune hemolytic anemiaJournal of Postgraduate Medicine, 2013
- Pure red cell aplasia accompanied by autoimmune hemolytic anemia in a patient with type A viral hepatitis.2009
- Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study GroupHaematologica, 2007
- Erythrocyte P Antigen: Cellular Receptor for B19 ParvovirusScience, 1993
- Pure Red Cell Aplasia following Autoimmune Haemolytic AnaemiaActa Haematologica, 1992
- DEMONSTRATION OF 2 DISTINCT ANTIBODIES IN AUTOIMMUNE HEMOLYTIC-ANEMIA WITH RETICULOCYTOPENIA AND RED-CELL APLASIA1984